Cyclopropylamine → 2-Methylpentane
Reaction equation
[Cl:1][C:2]1[C:3]([C:23]([N:25]2C=CN=[CH:26]2)=[O:24])=[C:4]([CH:19]=[CH:20][C:21]=1[Cl:22])[O:5][CH:6]1[CH2:11][CH2:10][N:9]([C:12]([O:14][C:15]([CH3:18])([CH3:17])[CH3:16])=[O:13])[CH2:8][CH2:7]1.[CH:30]1(N)C[CH2:31]1>>[CH3:20][CH2:21][CH2:2][CH:3]([CH3:23])[CH3:4].[Cl:1][C:2]1[C:3]([C:23]([NH:25][CH:26]2[CH2:31][CH2:30]2)=[O:24])=[C:4]([CH:19]=[CH:20][C:21]=1[Cl:22])[O:5][CH:6]1[CH2:7][CH2:8][N:9]([C:12]([O:14][C:15]([CH3:18])([CH3:17])[CH3:16])=[O:13])[CH2:10][CH2:11]1Participants
4
Procedure
A solution of tert-butyl 4-[3,4-dichloro-2-(1H-imidazol-1-ylcarbonyl)phenoxy]piperidine-1-carboxylate (described in Preparation 11 step 1) (2.0 g, 4.5 mmol) in cyclopropylamine (12 ml) was heated at 50° C. for 14 h. The solution was concentrated in vacuo then partitioned between ethyl acetate and 1N aqueous hydrochloric acid. The organics were dried over magnesium sulfate and concentrated in vacuo. Crystallization from dichloromethane:isohexane gave the title compound as a white solid (0.64 g).
Workup
- concentrationThe solution was concentrated in vacuo
- customthen partitioned between ethyl acetate and 1N aqueous hydrochloric acid
- dry with materialThe organics were dried over magnesium sulfate
- concentrationconcentrated in vacuo
- customCrystallization from dichloromethane
Sources & evidence
- ORD record
- ord-fcd0fcb5ddb04983b429d9cc413d79d5
- Source dataset
- uspto-grants-2010_05
- Patent number
- US07709500B2
Reaction notes
Loading…